Inventor profile of:

Sandra Steiner

City:

Sursee

Country:

Switzerland

Published Applications:

24

Last publication date:

2026-04-23

Top Assignees for applications by Sandra Steiner

The entities that hold a legal rights for patent applications filed by inventor Steiner Sandra:

Recent patent applications by Steiner Sandra

Sandra Steiner from Sursee, CH has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2026-04-23
US20260109689A1
Chemistry; metallurgy

NOVEL COMPOUNDS

#2 | 2026-04-02
US20260092076A1
Chemistry; metallurgy

NOVEL COMPOUNDS

#3 | 2026-04-02
US20260092073A1
Chemistry; metallurgy

NOVEL COMPOUNDS

#4 | 2026-01-15
US20260015353A1
Chemistry; metallurgy

NOVEL COMPOUNDS

#5 | 2025-11-20
US20250353830A1
Chemistry; metallurgy

NOVEL COMPOUNDS

#6 | 2025-10-09
US20250313565A1
Chemistry; metallurgy

NEW INDAZOLE DERIVATIVES

#7 | 2025-09-18
US20250289824A1
Chemistry; metallurgy

EGFR INHIBITOR FOR THE TREATMENT OF CANCER

#8 | 2025-09-04
US20250276958A1
Chemistry; metallurgy

COMPOUNDS

#9 | 2025-06-19
US20250197370A1
Chemistry; metallurgy

NOVEL COMPOUNDS

#10 | 2024-12-12
US20240409553A1
Chemistry; metallurgy

HETEROCYCLIC NLRP3 INHIBITORS

#11 | 2024-09-19
US20240308977A1
Chemistry; metallurgy

PYRIDAZINE DERIVATIVES AS INHIBITORS OF NLRP3

#12 | 2024-04-25
US20240132471A1
Chemistry; metallurgy

NOVEL COMPOUNDS

#13 | 2023-02-23
US20230054473A1
Chemistry; metallurgy

EGFR INHIBITORS FOR THE TREATMENT OF CANCER

#14 | 2022-10-06
US20220315593A1
Chemistry; metallurgy

EGFR INHIBITORS FOR THE TREATMENT OF CANCER

#15 | 2022-10-06
US20220315592A1
Chemistry; metallurgy

EGFR INHIBITOR FOR THE TREATMENT OF CANCER

#16 | 2022-10-06
US20220315591A1
Chemistry; metallurgy

NEW EGFR INHIBITORS

#17 | 2022-10-06
US20220315577A1
Chemistry; metallurgy

NEW EGFR INHIBITORS

#18 | 2022-05-05
US20220135571A1
Chemistry; metallurgy

THERAPEUTIC EGFR INHIBITORS

#19 | 2022-04-14
US20220112199A1
Chemistry; metallurgy

EGFR INHIBITOR FOR MEDICAL USE

#20 | 2021-04-01
US20210094945A1
Chemistry; metallurgy

Isoxazolyl ether derivatives as GABAα5 PAM

#21 | 2021-03-18
US20210079005A1
Chemistry; metallurgy

Isoindolinone derivatives as selective allosteric inhibitors of Egfr mutant cancers

#22 | 2021-03-11
US20210070739A1
Chemistry; metallurgy

2-benzopyrazinyl-n-heteroaryl-2-phenyl-acetamide compounds

#23 | 2020-11-19
US20200361930A1
Chemistry; metallurgy

BIFUNCTIONAL MOLECULES THAT DEGRADE EGFR

#24 | 2020-10-01
US20200308171A1
Chemistry; metallurgy

BIFUNCTIONAL INHIBITORS WITH EGFR HAVING A E3 UBIQUITIN LIGASE MOIETY

InventorID:

2863880 ⎘